Yıldız Dilbade Ekinci (Dilbade Yildiz Ekinci, Dilbade Yıldız Ekinci, Dilbade Yildiz Ekinci, Dilbade Yıldız Ekinci)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Optical Coherence Tomography

Finite Element Analysis

Replacement Therapy

Age Related Macular Degeneration

Top Venues

International ophthalmology

Ophthalmic epidemiology

Arquivos brasileiros de oftalmologia

Turkish journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Senay Guven Baysal, Yıldız Dilbade Ekinci, Nilufer Okur
Neurodevelopment of patients who received intravitreal bevacizumab or aflibercept for type 1 and aggressive retinopathy of prematurity. European journal of ophthalmology (2023)
Yıldız Dilbade Ekinci, Handan Bezirganoglu, Nilufer Okur, Muhammed Tas
A novel marker for predicting type 1 retinopathy of prematurity: C-reactive protein/albumin ratio. International ophthalmology (2023)
Bekir Kahveci, Yıldız Dilbade Ekinci
Evaluation of the relationship between HbA1c level and retina choroidal thickness in patients with gestational diabetes mellitus. Arquivos brasileiros de oftalmologia (2021)
Ibrahim Mert Erbas, Merih Çetinkaya, Yıldız Dilbade Ekinci, Seda Yılmaz Semerci
The possible effect of pentoxifylline on development and severity of retinopathy of prematurity. Cutaneous and ocular toxicology 40 (4) (2021)
Sadık Etka Bayramoğlu, Nihat Sayin, Yıldız Dilbade Ekinci, Nuray Aktay Ayaz, Mustafa Cakan
Anterior Segment Analysis and Evaluation of Corneal Biomechanical Properties in Children with Joint Hypermobility. Turkish journal of ophthalmology 50 (2) (2021)
Yıldız Dilbade Ekinci, Adem Ugurlu, Nurdan Gamze Taşlı
WHAT IS THE INCIDENCE OF RETINOPATHY OF PREMATURITY (ROP) IN 'BIG' BABIES?: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY. Ophthalmic epidemiology 28 (2) (2020)
Yıldız Dilbade Ekinci, Asli Deger Vural, Sadik Etka Bayramoglu, Ismail Umut Onur, Gulsum Oya Hergunsel
Assessment of vascular leakage and its development with FFA among patients treated with intravitreal anti-VEGF due to aggressive posterior ROP. International ophthalmology 39 (12) (2019)